3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
49
Phase 2
11
Phase 1
8
Phase 1/2
3
Phase 4
2
Phase EARLY_PHASE1
1
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
2
Interventions
Letrozole
5
Tamoxifen
4
Anastrozole
4
ribociclib
3
exemestane
3
atezolizumab
3
Vancomycin
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Injections
3
Human Papillomavirus Recombinant Vaccine nonavalent
3
Dexamethasone
3
Carboplatin
3
trametinib
2
relatlimab
2
pembrolizumab
2
encorafenib
2
dabrafenib
2
binimetinib
2
asciminib
2
Specimen Handling
2
Rituximab
2
Prednisone
2
Papillomavirus Vaccines
2
Oxaliplatin
2
Medroxyprogesterone Acetate
2
Leucovorin
2
Lenalidomide
2
Ipilimumab
2
Immune Checkpoint Inhibitors
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Blood Specimen Collection
×
90 days
×
Clear all
NCT06274515
2026-05-06
REMERGE
Hoffmann-La Roche
Phase 4
Recruiting
320 enrolled
NCT07490509
2026-04-01
DOSABEMA
Poitiers University Hospital
Phase 4
Not yet recruiting
235 enrolled